Back to News
Market Impact: 0.35

It's not just Terawulf, IREN shares are soaring because of Anthropic too

Artificial IntelligenceCompany FundamentalsTechnology & InnovationCorporate Earnings
It's not just Terawulf, IREN shares are soaring because of Anthropic too

Terawulf (WULF) is in focus after disclosing a $19B contracted revenue deal with Anthropic, signaling a major AI-driven demand tailwind. IREN Ltd (IREN) is also rallying, attributed to its associated AI research lab exposure. Overall, the headline contract size is a clear positive catalyst for both stocks, with potential for outsized near-term repricing.

Analysis

This is first and foremost a financing-quality upgrade, not just a revenue headline. For WULF, the market can now underwrite a more durable cash-flow stream, which should compress the equity risk premium and improve debt/equity funding terms if the contract is truly bankable. The key variable is not headline size but whether the company can convert that backlog into funded capacity without forcing heavy dilution; that is where the rerating either sticks or fails. IREN is catching a sympathy bid because the market is re-pricing the whole neocloud cohort, but its move is weaker unless it can show comparable contracted demand or a clearer cost advantage. Second-order winners are the infrastructure bottlenecks: power delivery, switchgear, transformers, and liquid-cooling vendors should see the real demand pull if these deployments move from press-release to rack installation. The less obvious loser is any AI hosting name trading purely on narrative without visible offtake or cheap power, because investors will start to discriminate between "capacity" and "bankable capacity." This also nudges capital away from commodity miners-turned-cloud stories and toward operators that can prove interconnect, uptime, and financing discipline. The contrarian risk is execution drag: contracted revenue can still be low-margin if GPU supply slips, power costs reset higher, or redundancy requirements eat returns. Near term, this is a momentum/short-squeeze setup for days to weeks; over 1-3 months the market will focus on capex, funding mix, and margin disclosure; over 6-18 months the question is whether these assets earn acceptable ROIC or simply grow revenue with poor equity returns. Consensus may be underestimating how much of the rally is a lower cost of capital story rather than a durable earnings inflection.